$75.54
+1.50 (+2.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+117.38%
1Y
+455.44%
YTD
+140.57%
Open$73.99
Previous Close$74.04
Day High$76.35
Day Low$72.22
52W High$73.22
52W Low$11.85
Volume—
Avg Volume3.24M
Market Cap6.32B
P/E Ratio283.35
EPS$0.16
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.31
Above
SMA 200
$25.48
Above
RSI (14)
31.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-42.9% upside
Current
$75.54
$75.54
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 163.60M | 12.24M | 783.80M |
| Net Income | -71,222,514 | -102,665,771 | 150.56M |
| Profit Margin | -43.5% | -885.1% | 19.2% |
| EBITDA | -53,063,396 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +115.0% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |